Puma Biotech (PBYI) Reports Q3 EPS of $0.17

Puma Biotech (NASDAQ: PBYI) reported Q3 EPS of $0.17, versus ($1.36) reported last year. Revenue for the quarter came in at $62.6 million versus the consensus estimate of $57.94 million.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• Trump discloses over $1.4 billion in crypto income in 2025 filing
• American Eagle Outfitters names new CFO, reaffirms 2026 guidance
• CareDx completes Naveris acquisition, adding cancer MRD testing